{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:30:23Z","timestamp":1769715023467,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10067-025-07773-6","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:29:22Z","timestamp":1762374562000},"page":"541-548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["VEXAS syndrome presenting with features of Sj\u00f6gren\u2019s disease: a case-based review of VEXAS and autoimmune disease overlap"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4292-4426","authenticated-orcid":false,"given":"Marwin","family":"Groener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailey","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijeet","family":"Danve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"27","key":"7773_CR1","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W et al (2020) Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med 383(27):2628\u20132638","journal-title":"N Engl J Med"},{"issue":"2","key":"7773_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/1744666X.2023.2157262","volume":"19","author":"A Al-Hakim","year":"2023","unstructured":"Al-Hakim A, Savic S (2023) An update on VEXAS syndrome. Expert Rev Clin Immunol 19(2):203\u2013215. https:\/\/doi.org\/10.1080\/1744666X.2023.2157262","journal-title":"Expert Rev Clin Immunol"},{"issue":"9","key":"7773_CR3","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D et al (2014) Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66(9):2613\u20132620","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"7773_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E et al (2022) Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol 186(3):564\u201374","journal-title":"Br J Dermatol"},{"issue":"1","key":"7773_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","volume":"149","author":"CI van der Made","year":"2022","unstructured":"van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL et al (2022) Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of patients with VEXAS. J Allergy Clin Immunol 149(1):432-439.e4","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"7773_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ajh.27169","volume":"99","author":"C Gurnari","year":"2024","unstructured":"Gurnari C, Pascale MR, Vitale A, Diral E, Tomelleri A, Galossi E et al (2024) Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort. Am J Hematol 99(2):254\u2013262","journal-title":"Am J Hematol"},{"key":"7773_CR7","doi-asserted-by":"crossref","unstructured":"Watanabe R, Kiji M, Hashimoto M (2022) Vasculitis associated with VEXAS syndrome: a literature review. Front Med (Lausanne) 9:983939","DOI":"10.3389\/fmed.2022.983939"},{"key":"7773_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae550","author":"MM Sullivan","year":"2024","unstructured":"Sullivan MM, Mead-Harvey C, Sartori-Valinotti JC, Kalantari K, Kusne YN, Patnaik MM et al (2024) Vasculitis associated with VEXAS syndrome. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keae550","journal-title":"Rheumatology"},{"key":"7773_CR9","unstructured":"Midtvedt \u00d8, Stray-Pedersen A, Andersson H, Gunnarsson R, Tveten K, Ali MM, Tj\u00f8nnfjord GE\u00a0(2022) A man in his sixties with chondritis and bone marrow failure. Tidsskr Nor Laegeforen 142(4). English, Norwegian"},{"issue":"11","key":"7773_CR10","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/art.42257","volume":"74","author":"M Itagane","year":"2022","unstructured":"Itagane M, Teruya H, Kato T, Tsuchida N, Maeda A, Kirino Y et al (2022) Clinical images: VEXAS syndrome presenting as treatment-refractory polyarteritis nodosa. Arthritis Rheumatol 74(11):1863\u20134","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"7773_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00403-022-02340-4","volume":"315","author":"V Afsahi","year":"2023","unstructured":"Afsahi V, Christensen RE, Alam M (2023) VEXAS syndrome in dermatology. Arch Dermatol Res 315(2):161\u20134","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"7773_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/art.41992","volume":"74","author":"F Muratore","year":"2022","unstructured":"Muratore F, Marvisi C, Castrignan\u00f2 P, Nicoli D, Farnetti E, Bonanno O et al (2022) VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis. Arthritis Rheumatol 74(4):665\u201370","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"7773_CR13","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1016\/j.mayocp.2021.06.006","volume":"96","author":"MJ Koster","year":"2021","unstructured":"Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO et al (2021Oct) Clinical heterogeneity of the VEXAS syndrome: a case series. Mayo Clin Proc 96(10):2653\u20132659","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"7773_CR14","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1093\/rheumatology\/keab782","volume":"61","author":"A P\u00e0mies","year":"2022","unstructured":"P\u00e0mies A, Ferr\u00e0s P, Bellaub\u00ed-Pallar\u00e9s N, Gim\u00e9nez T et al (2022) VEXAS syndrome: relapsing polychondritis and myelodysplastic syndrome with associated immunoglobulin A vasculitis. Rheumatology. 61(3):e69-71","journal-title":"Rheumatology."},{"issue":"1","key":"7773_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.reumae.2023.12.004","volume":"20","author":"MP Loeza-Uribe","year":"2024","unstructured":"Loeza-Uribe MP, Hinojosa-Azaola A, S\u00e1nchez-Hern\u00e1ndez BE, Crisp\u00edn JC, Apodaca-Ch\u00e1vez E, Ferrada MA et al (2024) VEXAS syndrome: clinical manifestations, diagnosis, and treatment. Reumatolog\u00eda Cl\u00ednica (English Edition) 20(1):47\u201356","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"issue":"7","key":"7773_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.7326\/L21-0023","volume":"174","author":"V Lacombe","year":"2021","unstructured":"Lacombe V, Kosmider O, Pr\u00e9vost M, Lavigne C, Urbanski G (2021) Severe joint involvement in VEXAS syndrome: a case report. Ann Intern Med 174(7):1025\u20137","journal-title":"Ann Intern Med"},{"issue":"9","key":"7773_CR17","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1093\/rheumatology\/keab211","volume":"60","author":"M Magnol","year":"2021","unstructured":"Magnol M, Couvaras L, Degbo\u00e9 Y, Delabesse E, Bulai-Livideanu C, Ruyssen-Witrand A et al (2021) VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy. Rheumatol Oxf Engl. 60(9):e314-5","journal-title":"Rheumatol Oxf Engl."},{"issue":"3","key":"7773_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.31138\/mjr.271223.eos","volume":"35","author":"H Jain","year":"2024","unstructured":"Jain H, Roy D, Mavidi S, Haldar S, Mondal S, Bhattacharya P et al (2024) Elderly onset spondyloarthropathy and VEXAS syndrome: a case report. Mediterr J Rheumatol 35(3):490\u20133","journal-title":"Mediterr J Rheumatol"},{"key":"7773_CR19","doi-asserted-by":"publisher","first-page":"1403808","DOI":"10.3389\/fimmu.2024.1403808","volume":"15","author":"R Pereira da Costa","year":"2024","unstructured":"Pereira da Costa R, Sapinho G, Bandeira M, Infante J, Marques T, Mimoso Santos C et al (2024) Case report: VEXAS syndrome: an atypical indolent presentation as sacroiliitis with molecular response to azacitidine. Front Immunol. 15:1403808","journal-title":"Front Immunol."},{"issue":"2","key":"7773_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.41957","volume":"74","author":"A Sharma","year":"2022","unstructured":"Sharma A, Naidu G, Deo P, Beck DB (2022) VEXAS syndrome with systemic lupus erythematosus- expanding the spectrum of associated conditions. Arthritis Rheumatol 74(2):369\u201371","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"7773_CR21","first-page":"764","volume":"42","author":"M Sall\u00e9s","year":"2024","unstructured":"Sall\u00e9s M, Fust\u00e0 X, Creus L, Esquius M, M\u00ednguez S (2024) Systemic lupus erythematosus in the elderly finally diagnosed as VEXAS syndrome. Clin Exp Rheumatol 42(3):764\u2013765","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"7773_CR22","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1093\/rheumatology\/keab866","volume":"61","author":"I Cordts","year":"2022","unstructured":"Cordts I, Hecker JS, Gauck D, Park J, H\u00e4rtl J, G\u00fcnthner R et al (2022) Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis. Rheumatology. 61(5):e117-9","journal-title":"Rheumatology."},{"issue":"12","key":"7773_CR23","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1111\/1346-8138.16535","volume":"49","author":"Y Matsuki","year":"2022","unstructured":"Matsuki Y, Kawai R, Suyama T, Katagiri K et al (2022) A case of VEXAS syndrome with myositis possibly associated with macrophage activation syndrome. J Dermatol. 49(12):e441-3","journal-title":"J Dermatol."},{"key":"7773_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152430","volume":"66","author":"A Vitale","year":"2024","unstructured":"Vitale A, Caggiano V, Martin-Nares E, Frassi M, Dagna L, Hissaria P et al (2024) Orbital\/ocular inflammatory involvement in VEXAS syndrome: data from the international AIDA network VEXAS registry. Semin Arthritis Rheum 66:152430","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"7773_CR25","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/s41433-024-03014-3","volume":"38","author":"M Abumanhal","year":"2024","unstructured":"Abumanhal M, Leibovitch I, Zisapel M et al (2024) Ocular and orbital manifestations in VEXAS syndrome. Eye 38(9):1748\u201354","journal-title":"Eye"},{"issue":"12","key":"7773_CR26","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1093\/rheumatology\/keac356","volume":"61","author":"JS Topilow","year":"2022","unstructured":"Topilow JS, Ospina Cardona D, Beck DB, Ferrada MA, McMahan ZH, Paik JJ (2022) Novel genetic mutation in myositis-variant of VEXAS syndrome. Rheumatol Oxf Engl. 61(12):e371-3","journal-title":"Rheumatol Oxf Engl."},{"issue":"12","key":"7773_CR27","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/ced\/llae288","volume":"49","author":"A Bao","year":"2024","unstructured":"Bao A, Munjal A, Reddy PS, Park E, Synkowski DR, Jedrych JJ et al (2024) Concurrent autoimmune blistering diseases in VEXAS syndrome: a report of two cases. Clin Exp Dermatol 49(12):1719\u20131721. https:\/\/doi.org\/10.1093\/ced\/llae288","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"7773_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102612","volume":"19","author":"L Antonini","year":"2020","unstructured":"Antonini L, Le Mauff B, Marcelli C, Aouba A, de Boysson H (2020) Rhupus: a systematic literature review. Autoimmun Rev 19(9):102612","journal-title":"Autoimmun Rev"},{"key":"7773_CR29","doi-asserted-by":"crossref","unstructured":"Bhalodia A, Bermea K, Schmidt J, Gilotra N, Barth AS, Adamo L, Paik JJ\u00a0(2024) Increased risk of myocarditis and arrythmias in anti-Ku-positive scleroderma-myositis overlap patients: a case series. Rheumatology (Oxford) 63(9):e268\u2013e269","DOI":"10.1093\/rheumatology\/keae199"},{"key":"7773_CR30","doi-asserted-by":"crossref","unstructured":"Szekanecz Z, McInnes IB, Schett G, Szamosi S, Benk\u0151 S, Sz\u0171cs G\u00a0(2021) Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol 17(10):585\u2013595","DOI":"10.1038\/s41584-021-00652-9"},{"issue":"7","key":"7773_CR31","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1016\/S2352-3026(22)00138-7","volume":"9","author":"MJ Hochman","year":"2022","unstructured":"Hochman MJ, DeZern AE (2022) Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin? Lancet Haematol 9(7):e523\u2013e534","journal-title":"Lancet Haematol"},{"issue":"8","key":"7773_CR32","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00011-023-01773-5","volume":"72","author":"A Cristiano","year":"2023","unstructured":"Cristiano A, Belardi R, Hajrullaj H, Fabiani E, Falconi G, Galossi E et al (2023) Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes. Inflamm Res 72(8):1695\u2013707","journal-title":"Inflamm Res"},{"issue":"2","key":"7773_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/rheumatology\/kev294","volume":"55","author":"A Mekinian","year":"2016","unstructured":"Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N et al (2016) Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology 55(2):291\u2013300. https:\/\/doi.org\/10.1093\/rheumatology\/kev294","journal-title":"Rheumatology"},{"issue":"7","key":"7773_CR34","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1016\/S2665-9913(25)00034-7","volume":"7","author":"A Al-Hakim","year":"2025","unstructured":"Al-Hakim A, Trikha R, Phyu Htut EE, Chowdhury O, MacLennan CA, Chee A et al (2025) Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study. Lancet Rheumatol 7(7):e472\u2013e484","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"7773_CR35","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41591-025-03623-9","volume":"31","author":"R Molteni","year":"2025","unstructured":"Molteni R, Fiumara M, Campochiaro C, Alfieri R, Pacini G, Licari E et al (2025) Mechanisms of hematopoietic clonal dominance in VEXAS syndrome. Nat Med 31(6):1911\u201324","journal-title":"Nat Med"},{"issue":"16","key":"7773_CR36","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16):1526\u20131533. https:\/\/doi.org\/10.1056\/NEJMoa021933","journal-title":"N Engl J Med"},{"issue":"9","key":"7773_CR37","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/art.39214","volume":"67","author":"E Theander","year":"2015","unstructured":"Theander E, Jonsson R, Sj\u00f6str\u00f6m B, Brokstad K, Olsson P, Henriksson G (2015) Prediction of Sj\u00f6gren\u2019s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling. Arthritis Rheumatol 67(9):2427\u20132436","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"7773_CR38","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1093\/rheumatology\/keae530","volume":"64","author":"Y Kirino","year":"2025","unstructured":"Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H et al (2025June 1) Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry. Rheumatol Oxf Engl 64(6):3872\u20133878","journal-title":"Rheumatol Oxf Engl"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07773-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07773-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07773-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:41:36Z","timestamp":1769679696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07773-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7773"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07773-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written consent for publication was obtained from our patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}